Absorbed dose to ovaries or uterus during a 131I-therapeutic of cancer or hyperthyroidism: Comparison between in vivo measurements by TLD and calculations

An LiF dosimeter placed inside the uterus will only give an approximate value of the dose delivered to gonads during theraphy by iodine-131. But we easily demonstrated that the dose measured by TLD dosimeter does not significantly differ for uterus and for ovaries, because of the similar position of...

Full description

Saved in:
Bibliographic Details
Published inThe International journal of applied radiation and isotopes Vol. 30; no. 10; pp. 643 - 646
Main Authors Briere, J., Philippon, B.
Format Journal Article
LanguageEnglish
Published United States Elsevier B.V 01.10.1979
Subjects
Female
Graves Disease - radiotherapy
Humans
Models, Biological
Ovary - radiation effects
Radiation Dosage
Thermoluminescent Dosimetry
Thyroid Neoplasms - radiotherapy
Uterus - radiation effects
Online AccessGet full text

Cover

More Information
Summary:An LiF dosimeter placed inside the uterus will only give an approximate value of the dose delivered to gonads during theraphy by iodine-131. But we easily demonstrated that the dose measured by TLD dosimeter does not significantly differ for uterus and for ovaries, because of the similar position of the source organs. Consequently we have placed in volunteer patients a LiF dosimeter inside the uterus. Experimental results were compared to the dose calculated by Robertson and Gorman's (1) method for ovaries and for uterus.
ISSN:0020-708X
DOI:10.1016/0020-708X(79)90081-4